Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic
Review of data supporting the use of probiotics for COVID-19 and mechanisms of action.
Baud et al., 8 May 2020, peer-reviewed, 5 authors.
Abstract: OPINION
published: 08 May 2020
doi: 10.3389/fpubh.2020.00186
Using Probiotics to Flatten the Curve
of Coronavirus Disease COVID-2019
Pandemic
David Baud 1 , Varvara Dimopoulou Agri 2 , Glenn R. Gibson 3 , Gregor Reid 4,5 and
Eric Giannoni 2*
1
Materno-Fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, University of
Lausanne, Lausanne, Switzerland, 2 Clinic of Neonatology, Department Woman-Mother-Child, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland, 3 Food and Nutritional Sciences, St Joseph’s Hospital, The University of
Reading, Reading, United Kingdom, 4 Department of Microbiology and Immunology, The University of Western Ontario,
London, ON, Canada, 5 Canadian R&D Centre for Human Microbiome and Probiotics, Lawson Health Research Institute,
London, ON, Canada
Keywords: COVID 19, probiotics, prebiotics, SARS-CoV-2, pandemics, coronavirus, respiratory infection
Please send us corrections, updates, or comments.
c19early involves the extraction of over 100,000 datapoints from
thousands of papers.
Community updates
help ensure high accuracy.
Vaccines and treatments are complementary. All practical, effective, and safe
means should be used based on risk/benefit analysis. No treatment, vaccine, or
intervention is 100% available and effective for all current and future
variants. We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit
